Celebrating 25 years Est 1999-2024
*Across 3 years $2276.64 only $796.82
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (Valneva) and VBI Vaccines Inc. (Nasdaq: VBIV) (VBI) today announced a partnership in select...
Approximately 6,000 participants 5 years of age and older will be enrolled in Lyme disease-endemic regions in Europe and the U.S. Pfizer Inc...
Pfizer will invest €90.5 million in Valneva Planned Phase 3 study confirmed to initiate in Q3 2022 Valneva SE (Nasdaq: VALN; Euronext Paris:...
L'OCRCVM permet la reprise de la négociation - CRV; SPOT; VLA; BKMT Canada NewsWire VANCOUVER, le 20 févr. 2019 VANCOUVER, le 20 févr...
IIROC Trading Resumption - CRV; SPOT; VLA; BKMT Canada NewsWire VANCOUVER, Feb. 20, 2019 VANCOUVER, Feb. 20, 2019 /CNW/ - Trading resumes in:...
Suspension de la négociation par l'OCRCVM - VLA Canada NewsWire VANCOUVER, le 19 avril 2018 VANCOUVER, le 19 avril 2018 /CNW/ - L'OCRCVM a...
IIROC Trading Halt - VLA Canada NewsWire VANCOUVER, April 19, 2018 VANCOUVER, April 19, 2018 /CNW/ - The following issues have been halted by...
L'OCRCVM permet la reprise de la négociation - VLA Canada NewsWire TORONTO, le 11 janv. 2018 TORONTO, le 11 janv. 2018 /CNW/ - Reprise des...
IIROC Trading Resumption - VLA Canada NewsWire TORONTO, Jan. 11, 2018 TORONTO, Jan. 11, 2018 /CNW/ - Trading resumes in: Company: VELA MINERALS...
Suspension de la négociation par l'OCRCVM - VLA Canada NewsWire VANCOUVER, le 18 juill. 2017 VANCOUVER, le 18 juill. 2017 /CNW/ - L'OCRCVM a...
IIROC Trading Halt - VLA Canada NewsWire VANCOUVER, July 18, 2017 VANCOUVER, July 18, 2017 /CNW/ - The following issues have been halted by...
Lyon, France, Nov. 09, 2016 (GLOBE NEWSWIRE) -- Valneva Reports Strong Business Performance in First Nine Months Company Increases...
LYON, France, March 26, 2015 (GLOBE NEWSWIRE) -- The vaccine was developed by the Chemo-Sero Therapeutic Research Institute (Kaketsuken) in...
LYON, France, March 20, 2015 (GLOBE NEWSWIRE) -- Valneva Reports Annual Results 2014 The company announces a significant improvement to its...
LYON, France, March 17, 2015 (GLOBE NEWSWIRE) -- Valneva announces signing of an exclusive license agreement on EB66® Cell Line for Human...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.